Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",21834,2088,1.33 [1.27-1.39],7.216950196746845e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAN,Aggrecan core protein,22107,2112,0.47 [0.41-0.54],1.918401258585996e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE,Angiotensin-converting enzyme,19470,1855,1.70 [1.45-1.99],5.728747877068359e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE2,Angiotensin-converting enzyme 2,21913,2105,1.76 [1.66-1.86],7.731169426272672e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP5,Tartrate-resistant acid phosphatase type 5,22448,2148,1.96 [1.78-2.15],8.943956885286186e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY1,Aminoacylase-1,22331,2138,1.85 [1.76-1.96],3.102019106997164e-110
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,18799,1796,1.59 [1.48-1.70],9.12707020095118e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA2,Adenosine deaminase 2,22230,2119,1.96 [1.81-2.13],1.4163174365619574e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22606,2166,2.20 [1.87-2.59],1.8608546186983018e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL2,ADAMTS-like protein 2,19475,1856,3.13 [2.83-3.46],1.4907715955438425e-111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRD1,Adhesion G-protein coupled receptor D1,19045,1813,1.87 [1.67-2.08],6.267988565326525e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE2,Adhesion G protein-coupled receptor E2,22429,2152,1.81 [1.59-2.06],4.582637616712277e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE5,Adhesion G protein-coupled receptor E5,22515,2156,1.82 [1.64-2.03],3.183037233562391e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG1,Adhesion G-protein coupled receptor G1,22222,2129,1.50 [1.45-1.55],7.778057630146173e-120
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG2,Adhesion G-protein coupled receptor G2,22331,2138,0.42 [0.36-0.48],6.850584794538575e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH1B,All-trans-retinol dehydrogenase,19045,1813,1.37 [1.30-1.45],7.13500357932264e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,21913,2105,1.47 [1.41-1.54],2.393762999057881e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADIPOQ,Adiponectin,19494,1852,0.54 [0.51-0.58],5.08969122126903e-79
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFM,Afamin,19494,1852,3.68 [2.95-4.58],2.81540360305313e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR2,Anterior gradient protein 2 homolog,21647,2071,1.18 [1.14-1.23],3.211365540079603e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR3,Anterior gradient protein 3,21787,2083,1.35 [1.28-1.44],1.6997419155643e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRN,Agrin,22429,2152,1.77 [1.62-1.94],1.371736171408658e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRP,Agouti-related protein,22551,2158,1.31 [1.22-1.41],4.811035158444993e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGXT,Serine--pyruvate aminotransferase,22331,2138,1.39 [1.33-1.46],1.6891446389091066e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22189,2127,1.14 [1.10-1.18],8.025601673897648e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B10,Aldo-keto reductase family 1 member B10,18933,1813,1.35 [1.28-1.43],8.296040825633781e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,18885,1799,1.38 [1.31-1.45],1.9387891283897984e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALCAM,CD166 antigen,22606,2166,2.28 [1.89-2.74],3.1884819449672825e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH1A1,Retinal dehydrogenase 1,22355,2147,1.48 [1.39-1.57],6.424530692795225e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22234,2132,1.29 [1.24-1.34],4.0436209083744207e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBP,Protein AMBP,22471,2151,2.16 [1.80-2.59],1.3746882726701181e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO2,Amphoterin-induced protein 2,22222,2129,1.79 [1.51-2.11],5.413756581962485e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMOT,Angiomotin,19045,1813,1.54 [1.38-1.72],1.9143524116361964e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2A,Pancreatic alpha-amylase,21444,2052,0.76 [0.70-0.83],7.978666803571491e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMY2B,Alpha-amylase 2B,20800,1990,0.75 [0.69-0.81],3.992862591844653e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT2,Angiopoietin-2,22508,2152,1.83 [1.67-2.01],2.3992873185927863e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL2,Angiopoietin-related protein 2,22358,2148,1.68 [1.53-1.84],1.0556708786074048e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL3,Angiopoietin-related protein 3,22375,2141,0.46 [0.41-0.51],7.341399664977051e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL4,Angiopoietin-related protein 4,22391,2150,1.31 [1.21-1.43],4.897062872217617e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL7,Angiopoietin-related protein 7,22508,2152,1.82 [1.66-2.01],8.497842276242405e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AOC3,Membrane primary amine oxidase,22460,2144,2.60 [2.29-2.94],2.3119937450363943e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA1,Apolipoprotein A-I,19494,1852,0.41 [0.34-0.49],3.0277460383491705e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA4,Apolipoprotein A-IV,19494,1852,1.53 [1.38-1.71],5.307270220760566e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOC1,Apolipoprotein C-I,19460,1848,0.37 [0.33-0.42],9.886819353401606e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOD,Apolipoprotein D,18662,1767,0.33 [0.29-0.38],6.292257518197226e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOF,Apolipoprotein F,19470,1855,0.49 [0.45-0.53],5.309270295649516e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOM,Apolipoprotein M,22412,2141,0.32 [0.28-0.36],3.975738709355709e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AREG,Amphiregulin,22222,2129,1.92 [1.78-2.07],6.682549709224162e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARSA,Arylsulfatase A,22355,2147,1.35 [1.25-1.46],2.603524567597506e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH1,Acid ceramidase,19269,1841,1.28 [1.19-1.39],9.225329830451644e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASAH2,Neutral ceramidase,22137,2130,1.64 [1.50-1.78],5.23218378252431e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR1,Asialoglycoprotein receptor 1,22137,2130,2.68 [2.40-2.98],1.9963045786479936e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASS1,Argininosuccinate synthase,18799,1796,1.31 [1.24-1.39],1.0721539171002944e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRN,"Attractin, Isoform 2",19494,1852,3.49 [2.72-4.47],5.674876128226133e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",18968,1809,2.35 [2.07-2.66],3.6649108002316927e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",22429,2152,1.57 [1.37-1.79],3.78459645882992e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,21834,2088,1.52 [1.44-1.59],2.2592669921424693e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAN,Brevican core protein,22137,2130,0.52 [0.47-0.58],6.604404153554097e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCHE,Cholinesterase,19109,1818,1.73 [1.45-2.05],8.376883834056115e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGLAP,Osteocalcin,19475,1856,0.83 [0.79-0.87],7.528122849458095e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMPER,BMP-binding endothelial regulator protein,19045,1813,2.95 [2.49-3.50],2.546169192435986e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BPIFB2,BPI fold-containing family B member 2,19420,1848,1.24 [1.17-1.32],1.1662060340551344e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST2,Bone marrow stromal antigen 2,22509,2156,1.39 [1.30-1.47],4.4303216505960216e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN2A1,Butyrophilin subfamily 2 member A1,22429,2152,1.55 [1.36-1.77],5.38691534402716e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C19orf12,Protein C19orf12,21826,2083,1.34 [1.28-1.41],4.795431833596804e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22460,2144,1.88 [1.74-2.02],5.2258178472080923e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2,Complement C2,22412,2141,3.18 [2.62-3.87],1.959258472865784e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C3,Complement C3,18470,1746,1.48 [1.36-1.60],8.013075338793527e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7,Complement component C7,19008,1806,2.51 [2.19-2.89],3.6850274515461e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C9,Complement component C9,19470,1855,0.77 [0.72-0.83],5.2814127316728814e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA12,Carbonic anhydrase 12,22222,2129,1.49 [1.33-1.67],8.344277413167917e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA14,Carbonic anhydrase 14,22508,2152,0.48 [0.43-0.53],3.7871149181118135e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",21913,2105,1.21 [1.17-1.26],8.066324107779739e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA9,Carbonic anhydrase 9,22508,2152,1.31 [1.22-1.41],3.651702547825978e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCA,Calcitonin,22104,2129,1.23 [1.16-1.29],2.2415399987742194e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLIF,Cobalamin binding intrinsic factor,22288,2136,1.24 [1.18-1.30],8.1683313147079e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBS,Cystathionine beta-synthase,18968,1809,1.45 [1.36-1.56],3.783290610560096e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL11,Eotaxin,22551,2158,1.50 [1.35-1.66],1.8748425589223733e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL15,C-C motif chemokine 15,22606,2166,1.79 [1.65-1.93],1.5754056354425138e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL16,C-C motif chemokine 16,22606,2166,1.43 [1.33-1.54],2.932842059892725e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL20,C-C motif chemokine 20,22551,2158,1.23 [1.19-1.28],9.928311118647102e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL21,C-C motif chemokine 21,22429,2152,1.35 [1.26-1.44],3.989271933923503e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL25,C-C motif chemokine 25,22551,2158,1.31 [1.21-1.41],2.363603052114868e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL3,C-C motif chemokine 3,22279,2137,1.17 [1.12-1.23],9.138899181039368e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL7,C-C motif chemokine 7,22279,2137,1.22 [1.15-1.29],6.409521725967459e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN4,CCN family member 4,22508,2152,1.45 [1.32-1.58],2.171723003516984e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD109,CD109 antigen,22355,2147,1.56 [1.39-1.75],3.2794717581624546e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,22460,2144,1.61 [1.49-1.75],7.911917617359849e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164,Sialomucin core protein 24,22355,2147,1.41 [1.29-1.55],1.5656629682419157e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD22,B-cell receptor CD22,22551,2158,1.35 [1.25-1.47],4.3318088996001554e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD244,Natural killer cell receptor 2B4,22551,2158,1.56 [1.36-1.78],3.1983108884251993e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD248,Endosialin,19475,1856,0.58 [0.52-0.65],8.544201420567087e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD27,CD27 antigen,22422,2149,1.41 [1.30-1.54],1.5251945755156072e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD276,CD276 antigen,22325,2139,1.68 [1.50-1.87],7.036812579383595e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD28,T-cell-specific surface glycoprotein CD28,21834,2088,1.42 [1.30-1.56],8.160266377731533e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300C,CMRF35-like molecule 6,22509,2156,1.43 [1.30-1.59],3.088044153808304e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LG,CMRF35-like molecule 9,22355,2147,0.57 [0.51-0.63],9.429160735029154e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD302,CD302 antigen,22222,2129,1.48 [1.32-1.66],2.0974445226261143e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD34,Hematopoietic progenitor cell antigen CD34,22449,2154,0.49 [0.42-0.57],1.2845392572683033e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD4,T-cell surface glycoprotein CD4,22242,2132,1.51 [1.36-1.67],7.444044442801928e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD48,CD48 antigen,22391,2150,1.59 [1.41-1.79],8.625388145569383e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5,T-cell surface glycoprotein CD5,22471,2151,1.49 [1.37-1.62],5.709176435467913e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD74,HLA class II histocompatibility antigen gamma chain,22509,2156,1.58 [1.43-1.75],3.600662468667532e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD80,T-lymphocyte activation antigen CD80,19462,1849,2.11 [1.89-2.36],2.007976246383939e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD83,CD83 antigen,22279,2137,1.58 [1.42-1.75],1.4669474742401904e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,22509,2156,1.32 [1.23-1.42],7.569247809401888e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDCP1,CUB domain-containing protein 1,22137,2130,1.47 [1.38-1.57],8.068020346578909e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH1,Cadherin-1,21625,2059,1.76 [1.64-1.90],2.459277958175366e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH15,Cadherin-15,22476,2155,1.36 [1.30-1.43],1.194389043725158e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH17,Cadherin-17,22331,2138,1.43 [1.36-1.51],2.5639579464182644e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH2,Cadherin-2,22331,2138,2.48 [2.24-2.74],3.9778312424168114e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDHR2,Cadherin-related family member 2,22222,2129,1.48 [1.40-1.57],5.655084170444245e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22385,2142,1.81 [1.53-2.14],2.803233307295392e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19369,1846,1.20 [1.13-1.27],6.71088753948031e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21570,2065,1.21 [1.14-1.28],1.6947474313297387e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEMIP2,Cell surface hyaluronidase,18885,1799,1.45 [1.33-1.59],8.50610765121042e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES1,Liver carboxylesterase 1,22407,2150,1.43 [1.38-1.49],8.181194225373878e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES2,Cocaine esterase,22222,2129,1.42 [1.34-1.51],2.764769780126706e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES3,Carboxylesterase 3,22222,2129,1.19 [1.13-1.25],4.838178105685762e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFB,Complement factor B,19140,1808,2.11 [1.83-2.43],1.9531881649345893e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFC1,Cryptic protein,21834,2088,1.30 [1.20-1.41],1.466487709213054e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFH,Complement factor H,18338,1727,2.82 [2.30-3.46],2.090305518002238e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFI,Complement factor I,19494,1852,4.10 [3.26-5.15],1.1701693080996821e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGREF1,Cell growth regulator with EF hand domain protein 1,22331,2138,1.44 [1.32-1.58],2.3551506204190554e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAD,Chondroadherin,19045,1813,0.52 [0.48-0.57],8.135785986183001e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19425,1849,1.65 [1.51-1.80],7.04517552693958e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHI3L1,Chitinase-3-like protein 1,21891,2088,1.27 [1.21-1.32],6.010904742144634e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHL1,Neural cell adhesion molecule L1-like protein,22428,2141,0.65 [0.57-0.74],1.4781586102139055e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL2,Chordin-like protein 2,22331,2138,1.34 [1.24-1.46],3.704597725536936e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CILP,Cartilage intermediate layer protein 1,19475,1856,1.66 [1.52-1.82],4.182561970156854e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKB,Creatine kinase B-type,19475,1856,0.58 [0.53-0.62],5.550534572487459e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC3B,Tetranectin,19030,1800,0.35 [0.28-0.43],2.2624289529309297e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4A,C-type lectin domain family 4 member A,22279,2137,0.66 [0.60-0.73],1.503229717660878e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4D,C-type lectin domain family 4 member D,22279,2137,1.24 [1.17-1.32],4.799968238293765e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4M,C-type lectin domain family 4 member M,19440,1854,0.75 [0.68-0.82],5.98356771063958e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN2,Calsyntenin-2,22551,2158,1.47 [1.34-1.60],1.2124108530548008e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLUL1,Clusterin-like protein 1,22295,2134,0.72 [0.66-0.79],8.218282469363814e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN3,Contactin-3,22355,2147,2.64 [2.32-3.00],3.401864251755396e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN4,Contactin-4,22355,2147,1.74 [1.48-2.03],8.180015493476621e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL15A1,Collagen alpha-1(XV) chain,19475,1856,0.59 [0.50-0.70],4.728070731056734e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL18A1,Collagen alpha-1(XVIII) chain,22449,2145,1.97 [1.68-2.30],3.2034518792208304e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL3A1,Collagen alpha-1(III) chain,19475,1856,2.12 [1.78-2.54],1.3636453088221762e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL5A1,Collagen alpha-1(V) chain,19045,1813,1.56 [1.41-1.73],2.4707281239197762e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL6A3,Collagen alpha-3(VI) chain,22606,2166,1.59 [1.44-1.75],6.283440181496005e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COLEC12,Collectin-12,22325,2139,1.63 [1.42-1.86],2.668326295690044e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA2,Carboxypeptidase A2,22444,2152,1.33 [1.25-1.40],2.3198302089703788e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPM,Carboxypeptidase M,22386,2142,3.14 [2.85-3.45],1.056917036157723e-120
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPQ,Carboxypeptidase Q,19434,1854,1.54 [1.36-1.74],7.011530115704449e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR2,Complement receptor type 2,22460,2144,1.36 [1.26-1.48],1.6509469353223677e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD1,Protein disulfide isomerase CRELD1,19045,1813,2.05 [1.82-2.31],1.281663949720945e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRH,Corticoliberin,21797,2086,0.79 [0.76-0.83],5.991111705499486e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHBP,Corticotropin-releasing factor-binding protein,22325,2139,2.49 [2.17-2.86],6.377636694034826e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIP2,Cysteine-rich protein 2,22137,2130,1.38 [1.26-1.51],2.1666005428593165e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAC1,Cartilage acidic protein 1,22606,2166,0.59 [0.52-0.66],8.039529636172109e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1,Macrophage colony-stimulating factor 1,22429,2152,1.90 [1.67-2.18],3.954634579106128e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,19470,1855,1.57 [1.41-1.74],2.24836531497428e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST3,Cystatin-C,22426,2139,1.58 [1.40-1.79],3.240370577680839e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTBS,Di-N-acetylchitobiase,19168,1827,2.26 [1.90-2.68],6.439674201573661e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTRC,Chymotrypsin-C,22327,2146,0.82 [0.77-0.86],4.92660336540971e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSB,Cathepsin B,22381,2135,0.71 [0.66-0.77],7.29150033337996e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSD,Cathepsin D,20932,2006,1.95 [1.82-2.08],3.8718687179271003e-82
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSE,Cathepsin E,19045,1813,1.39 [1.28-1.52],4.2495944835149496e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSL,Cathepsin L1,22331,2138,1.75 [1.51-2.04],2.474798521657704e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSO,Cathepsin O,22551,2158,2.79 [2.52-3.09],4.539849888711096e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSS,Cathepsin S,17465,1694,2.44 [2.02-2.95],1.3322810331456831e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSZ,Cathepsin Z,22399,2135,1.85 [1.65-2.07],3.090422028133418e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL16,C-X-C motif chemokine 16,22577,2164,1.66 [1.42-1.95],2.1529208599837623e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL17,C-X-C motif chemokine 17,22551,2158,1.36 [1.25-1.48],1.2608787456456549e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CYTL1,Cytokine-like protein 1,19475,1856,0.53 [0.45-0.64],6.742278165134118e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAG1,Dystroglycan,22429,2152,1.42 [1.31-1.54],5.665531491047203e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22422,2149,1.82 [1.64-2.02],6.050919381520778e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCXR,L-xylulose reductase,22422,2149,1.49 [1.39-1.59],1.661102612064062e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22222,2129,1.40 [1.29-1.52],3.432964762033977e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDR1,Epithelial discoidin domain-containing receptor 1,22509,2156,1.82 [1.56-2.12],3.266732763014384e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIPK2B,Divergent protein kinase domain 2B,19045,1813,0.59 [0.50-0.69],2.376921543910382e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK4,Dickkopf-related protein 4,22104,2126,1.45 [1.34-1.56],1.2110529006143072e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL1,Delta-like protein 1,22422,2149,1.48 [1.32-1.67],1.0445643490356364e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMP1,Dentin matrix acidic phosphoprotein 1,18968,1809,0.60 [0.57-0.64],3.7274021199109513e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP10,Inactive dipeptidyl peptidase 10,22279,2137,1.50 [1.37-1.65],1.2926229386554679e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,22222,2129,1.95 [1.75-2.18],5.200524639704926e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPY30,Protein dpy-30 homolog,22428,2147,1.28 [1.21-1.35],9.223156348063372e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSC2,Desmocollin-2,22126,2125,1.57 [1.42-1.75],1.1531766222618378e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSCAM,Down syndrome cell adhesion molecule,19419,1844,1.75 [1.55-1.98],2.0307401633321009e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG2,Desmoglein-2,22355,2147,0.64 [0.56-0.74],3.73282937780848e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG4,Desmoglein-4,22156,2123,0.78 [0.72-0.84],1.6130219213355544e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTNB,Dystrobrevin beta,19327,1835,1.54 [1.40-1.70],2.911413625244805e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19462,1849,1.29 [1.22-1.36],8.822076736716054e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",18968,1809,1.18 [1.13-1.24],1.574422865971658e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,22508,2152,1.38 [1.25-1.51],2.097985102014127e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA4,Ephrin-A4,22101,2129,1.94 [1.76-2.15],2.069180650376745e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGLN1,Egl nine homolog 1,22279,2137,1.20 [1.13-1.27],2.5310991822157153e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21596,2064,1.28 [1.22-1.34],1.4784305525892474e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,21834,2088,1.41 [1.30-1.53],2.2272843487217058e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,21913,2105,0.57 [0.48-0.67],9.149728898849827e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA2,Ephrin type-A receptor 2,21514,2051,1.47 [1.32-1.64],7.345770025549317e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPO,Erythropoietin,22279,2137,1.17 [1.12-1.23],1.0841793699078359e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22466,2151,1.81 [1.62-2.02],1.578296463829586e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,22422,2149,2.39 [2.05-2.79],5.29853577991483e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,22422,2149,1.67 [1.43-1.95],8.8081286493233e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESM1,Endothelial cell-specific molecule 1,22325,2139,0.63 [0.56-0.70],4.205751208700778e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EZR,Ezrin,22509,2156,1.63 [1.41-1.88],3.6691469993614114e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11R,Junctional adhesion molecule A,22355,2147,1.25 [1.17-1.33],8.040945683934969e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F9,Coagulation factor IX,22412,2141,3.22 [2.62-3.95],6.199345873399897e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP1,"Fatty acid-binding protein, liver",22325,2139,1.40 [1.35-1.45],2.3985201567669785e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP3,"Fatty acid-binding protein, heart",19462,1849,1.39 [1.28-1.50],4.80867007584732e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP4,"Fatty acid-binding protein, adipocyte",22606,2166,1.53 [1.43-1.64],4.55545051954878e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM20A,Pseudokinase FAM20A,19462,1849,2.08 [1.84-2.36],6.200304756023349e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3B,Protein FAM3B,22222,2129,1.62 [1.45-1.80],1.6231120357657078e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3C,Protein FAM3C,22288,2136,2.04 [1.81-2.30],1.493824798472441e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3D,Protein FAM3D,19369,1846,1.30 [1.24-1.37],3.051813185893688e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAS,Tumor necrosis factor receptor superfamily member 6,22541,2159,1.38 [1.26-1.50],1.9137279156944426e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FASLG,Tumor necrosis factor ligand superfamily member 6,22551,2158,0.66 [0.59-0.73],5.927362612287055e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBP1,"Fructose-1,6-bisphosphatase 1",22331,2138,1.24 [1.18-1.30],1.081030098389385e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19462,1849,1.53 [1.44-1.62],1.038565321027595e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAR,Immunoglobulin alpha Fc receptor,22279,2137,1.32 [1.22-1.42],4.3962787320596186e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FETUB,Fetuin-B,22412,2141,1.52 [1.34-1.73],1.8061896132372047e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF21,Fibroblast growth factor 21,22470,2148,1.25 [1.21-1.29],8.105912181430748e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF23,Fibroblast growth factor 23,22477,2147,1.33 [1.25-1.41],4.0278697218455123e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP1,Fibroblast growth factor-binding protein 1,22422,2149,0.33 [0.30-0.37],9.496488412780512e-85
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP3,Fibroblast growth factor-binding protein 3,19425,1849,0.62 [0.54-0.70],1.75935128558198e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR2,Fibroblast growth factor receptor 2,22422,2149,3.66 [3.17-4.22],4.5195576823179845e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FST,Follistatin,22391,2150,0.77 [0.71-0.84],3.7557798695758814e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL3,Follistatin-related protein 3,22287,2141,1.50 [1.34-1.68],4.679041674626471e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FTCD,Formimidoyltransferase-cyclodeaminase,19381,1843,1.49 [1.42-1.56],1.1877674162147654e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUOM,Fucose mutarotase,19045,1813,1.59 [1.49-1.70],4.3471335306677965e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FURIN,Furin,22422,2149,2.02 [1.80-2.27],2.006775604873509e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAL,Galanin peptides,22429,2152,0.82 [0.78-0.87],7.970487821483179e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22222,2129,2.23 [1.95-2.54],1.0812451030973784e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,21900,2081,1.46 [1.34-1.59],9.433800751332836e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAST,Gastrin,19425,1849,1.10 [1.07-1.13],4.933811702913599e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCG,Pro-glucagon,21834,2088,1.26 [1.22-1.30],5.5598353019533785e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22222,2129,1.47 [1.32-1.64],2.8073218207653983e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF15,Growth/differentiation factor 15,22606,2166,2.61 [2.45-2.77],1.5278748521188357e-210
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDNF,Glial cell line-derived neurotrophic factor,21826,2083,1.45 [1.32-1.59],3.537459055338049e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA1,GDNF family receptor alpha-1,22470,2148,2.12 [1.87-2.40],2.6542050921389465e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGH,Gamma-glutamyl hydrolase,22001,2096,1.59 [1.43-1.76],5.911745218899675e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT1,Glutathione hydrolase 1 proenzyme,22323,2146,1.71 [1.61-1.82],2.212574139069837e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT5,Glutathione hydrolase 5 proenzyme,22137,2130,2.30 [1.98-2.67],3.642191816268881e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHR,Growth hormone receptor,19045,1813,1.84 [1.56-2.17],4.165668820726265e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRL,Appetite-regulating hormone,22331,2138,0.87 [0.83-0.91],5.19093901386912e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC2,PDZ domain-containing protein GIPC2,19425,1849,1.58 [1.38-1.80],1.83444537787604e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLA,Alpha-galactosidase A,19017,1812,2.06 [1.85-2.30],2.740516569839429e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLB1,Beta-galactosidase,22137,2130,1.49 [1.36-1.63],2.1002274290319616e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLM2,Protein GOLM2,22509,2156,2.28 [2.02-2.57],1.0673565833756448e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPD1,Glycerol-3-phosphate dehydrogenase,19371,1841,1.73 [1.61-1.85],1.143933891953241e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPNMB,Transmembrane glycoprotein NMB,21720,2086,1.80 [1.58-2.06],6.114289633933672e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR37,Prosaposin receptor GPR37,21913,2105,1.37 [1.30-1.45],2.3999523815522783e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPRC5C,G-protein coupled receptor family C group 5 member C,19371,1841,1.47 [1.38-1.57],1.081421097750548e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRN,Progranulin,22250,2139,1.64 [1.40-1.91],3.0618397702627605e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",22222,2129,1.36 [1.28-1.44],6.4992322402095876e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSN,Gelsolin,19405,1851,0.42 [0.38-0.47],4.5101823170142245e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA1,Glutathione S-transferase A1,22292,2135,1.40 [1.35-1.46],1.1767486803529809e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSTA3,Glutathione S-transferase A3,21834,2088,1.36 [1.31-1.43],3.975440199836785e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUSB,Beta-glucuronidase,22448,2148,1.61 [1.52-1.70],6.002743516075048e-63
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAO1,Hydroxyacid oxidase 1,22508,2152,1.27 [1.24-1.31],1.0871901314711252e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR1,Hepatitis A virus cellular receptor 1,22471,2151,1.64 [1.56-1.73],4.7398543563021155e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR2,Hepatitis A virus cellular receptor 2,22355,2147,1.55 [1.40-1.71],1.1963039005418069e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEG1,Protein HEG homolog 1,19045,1813,3.03 [2.59-3.55],1.3592530181318376e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPH,Hephaestin,19462,1849,3.16 [2.65-3.78],6.210139908043511e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGF,Hepatocyte growth factor,22551,2158,2.54 [2.31-2.79],3.643116487823316e-84
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1R,Huntingtin-interacting protein 1-related protein,19379,1843,1.41 [1.31-1.51],2.5215255749064934e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HJV,Hemojuvelin,19419,1844,1.33 [1.23-1.44],2.5058609900929205e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMCN2,Hemicentin-2,19016,1812,1.30 [1.20-1.41],1.9893994443304607e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNMT,Histamine N-methyltransferase,22033,2127,1.31 [1.21-1.41],1.3907043229500209e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22279,2137,0.48 [0.44-0.53],1.0117702692646106e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19425,1849,1.32 [1.23-1.42],3.4305666498609773e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYAL1,Hyaluronidase-1,22246,2122,2.34 [2.02-2.71],5.007810133871753e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM1,Intercellular adhesion molecule 1,22263,2126,2.01 [1.78-2.26],7.096586408046512e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM4,Intercellular adhesion molecule 4,22279,2137,0.74 [0.69-0.80],8.195371156367469e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDUA,Alpha-L-iduronidase,22508,2152,1.68 [1.54-1.83],7.295342391736544e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,18888,1807,1.62 [1.46-1.80],3.1952711716492724e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR2,Interferon gamma receptor 2,22137,2130,1.44 [1.34-1.54],5.5221008292688e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2R,Cation-independent mannose-6-phosphate receptor,22355,2147,2.52 [2.14-2.96],7.531491655931617e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP1,Insulin-like growth factor-binding protein 1,22571,2164,0.78 [0.75-0.80],4.8962653167978466e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP2,Insulin-like growth factor-binding protein 2,22580,2163,0.65 [0.61-0.69],8.162827339877657e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP4,Insulin-like growth factor-binding protein 4,22065,2124,1.41 [1.31-1.52],1.7495640098116314e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP7,Insulin-like growth factor-binding protein 7,22606,2166,1.68 [1.52-1.85],7.605966000228501e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22331,2138,1.74 [1.57-1.92],8.617607782395714e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF3,Immunoglobulin superfamily member 3,22222,2129,2.15 [2.02-2.30],2.9867389978477673e-122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF8,Immunoglobulin superfamily member 8,22331,2138,1.92 [1.71-2.15],5.38507798470089e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF9,Protein turtle homolog A,19462,1849,1.73 [1.65-1.81],4.245703091359604e-108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RB,Interleukin-10 receptor subunit beta,22429,2152,1.81 [1.63-2.02],2.8004794644704797e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12A_IL12B,Interleukin-12,22222,2129,1.17 [1.12-1.23],3.1390114031288516e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12B,Interleukin-12 subunit beta,22551,2158,1.26 [1.18-1.35],1.5502458681164722e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB1,Interleukin-12 receptor subunit beta-1,21900,2081,1.43 [1.30-1.57],1.1131502942867628e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17C,Interleukin-17C,21900,2081,1.18 [1.13-1.24],3.0211746623125564e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17RB,Interleukin-17 receptor B,22011,2118,0.70 [0.65-0.75],2.850622227717819e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18,Interleukin-18,22257,2134,1.40 [1.30-1.52],1.3474946478912184e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18BP,Interleukin-18-binding protein,22460,2144,1.60 [1.43-1.79],1.3775122710656062e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18R1,Interleukin-18 receptor 1,22551,2158,3.25 [2.93-3.61],3.486545625362885e-107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL19,Interleukin-19,21762,2095,1.17 [1.11-1.23],9.484189189954374e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R1,Interleukin-1 receptor type 1,22323,2146,2.56 [2.18-2.99],9.554712253575267e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R2,Interleukin-1 receptor type 2,22289,2134,3.60 [2.97-4.37],1.926586628601767e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL1,Interleukin-1 receptor-like 1,22541,2159,1.38 [1.26-1.50],1.8770948274812665e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RN,Interleukin-1 receptor antagonist protein,22293,2140,1.64 [1.55-1.73],2.2976998691352666e-72
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6,Interleukin-6,22222,2129,1.21 [1.16-1.26],3.2335860123218934e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6ST,Interleukin-6 receptor subunit beta,22331,2138,2.42 [1.97-2.98],7.968136457206268e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMMT,MICOS complex subunit MIC60,19371,1841,1.52 [1.40-1.65],7.59116734618077e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBC,Inhibin beta C chain,22355,2147,2.01 [1.82-2.23],1.2106348053736052e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL5,Insulin-like peptide INSL5,19369,1846,1.16 [1.11-1.21],1.2696681965337392e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA11,Integrin alpha-11,22279,2137,0.64 [0.58-0.72],1.4514914853133194e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA5,Integrin alpha-5,22355,2147,2.69 [2.33-3.11],2.582881030258715e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAV,Integrin alpha-V,22508,2152,0.33 [0.26-0.41],8.304528064055987e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB2,Integrin beta-2,22213,2137,1.78 [1.56-2.04],8.953855068881393e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGBL1,Integrin beta-like protein 1,19475,1856,1.88 [1.71-2.07],5.330853204126108e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KHK,Ketohexokinase,18968,1809,1.58 [1.47-1.69],1.4936162617791676e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KIT,Mast/stem cell growth factor receptor Kit,22412,2141,0.66 [0.58-0.75],7.838045903100903e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KITLG,Kit ligand,22331,2138,0.70 [0.63-0.77],5.630362849602269e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK14,Kallikrein-14,22508,2152,0.77 [0.71-0.84],6.97562665811113e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK4,Kallikrein-4,22508,2152,1.20 [1.13-1.27],4.96449362128392e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,22551,2158,1.76 [1.61-1.93],3.6168110183317694e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT18,"Keratin, type I cytoskeletal 18",22222,2129,1.45 [1.39-1.50],6.255451813935092e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT19,"Keratin, type I cytoskeletal 19",22234,2132,1.33 [1.26-1.40],1.0756745683474683e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT8,"Keratin, type II cytoskeletal 8",18824,1792,1.30 [1.26-1.35],2.818231667872809e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KYNU,Kynureninase,22551,2158,1.61 [1.49-1.74],1.1374037825005768e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22325,2139,1.34 [1.23-1.45],4.5000321958971396e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMB1,Laminin subunit beta-1,18968,1809,2.25 [1.94-2.62],5.448791922247054e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP1,Lysosome-associated membrane glycoprotein 1,18913,1805,1.37 [1.26-1.50],2.351345343531749e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMP2,Lysosome-associated membrane glycoprotein 2,21651,2089,2.49 [2.05-3.03],7.554035564583371e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBP,Lipopolysaccharide-binding protein,22460,2144,1.26 [1.18-1.35],2.2137945645904888e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCAT,Phosphatidylcholine-sterol acyltransferase,19470,1855,1.96 [1.58-2.42],6.33909033472079e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLR,Low-density lipoprotein receptor,22388,2146,1.28 [1.19-1.38],1.5360543945723823e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEP,Leptin,22331,2138,1.29 [1.22-1.37],1.0451271760194295e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3BP,Galectin-3-binding protein,19494,1852,1.76 [1.59-1.95],3.357197304722875e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS4,Galectin-4,22325,2139,2.15 [2.02-2.28],1.3201958035782013e-140
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS9,Galectin-9,22326,2143,1.66 [1.48-1.87],3.9436370032191495e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGMN,Legumain,22429,2152,1.41 [1.27-1.57],1.1779050000325828e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIFR,Leukemia inhibitory factor receptor,22279,2137,2.49 [2.17-2.87],1.0418908182452585e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22288,2136,1.49 [1.32-1.67],3.3407143343771386e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPL,Lipoprotein lipase,22331,2138,0.53 [0.50-0.56],8.706292513546481e-92
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPO,Lactoperoxidase,21567,2077,1.41 [1.33-1.50],7.779484967157695e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,21834,2088,1.24 [1.16-1.32],2.2007180984359568e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22062,2125,1.25 [1.18-1.34],1.0361363874862017e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC4,Apical endosomal glycoprotein,19371,1841,1.49 [1.38-1.61],1.9493000285895288e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN2B2,Epididymis-specific alpha-mannosidase,19462,1849,1.34 [1.24-1.44],2.507900792778184e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MARCO,Macrophage receptor MARCO,22331,2138,1.62 [1.40-1.87],8.09838083659045e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MASP1,Mannan-binding lectin serine protease 1,22104,2129,1.88 [1.60-2.22],5.5943770962031565e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN3,Matrilin-3,22101,2129,0.45 [0.40-0.51],3.799127232615431e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MCAM,Cell surface glycoprotein MUC18,22460,2144,0.67 [0.60-0.75],1.5637808680094288e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MENT,Protein MENT,19045,1813,0.32 [0.27-0.39],2.6029016896896767e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1A,Meprin A subunit alpha,19369,1846,1.31 [1.24-1.39],2.8593967404640867e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEPE,Matrix extracellular phosphoglycoprotein,22325,2139,0.63 [0.55-0.72],7.017242783842259e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MET,Hepatocyte growth factor receptor,22385,2148,0.32 [0.27-0.39],7.981111607551358e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP4,Microfibril-associated glycoprotein 4,19045,1813,1.94 [1.69-2.22],7.369240467707674e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFGE8,Lactadherin,22355,2147,1.95 [1.80-2.12],2.609635835330313e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MME,Neprilysin,22222,2129,1.42 [1.36-1.49],5.654469136583372e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP12,Macrophage metalloelastase,22328,2141,1.50 [1.40-1.60],9.326399945173164e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP7,Matrilysin,21879,2102,1.54 [1.41-1.67],1.3801900361899268e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP9,Matrix metalloproteinase-9,22310,2143,1.24 [1.16-1.32],7.385428438828844e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRC1,Macrophage mannose receptor 1,19470,1855,1.83 [1.58-2.12],1.1999396096790926e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSR1,Macrophage scavenger receptor types I and II,22509,2156,1.69 [1.56-1.84],2.9020470616340423e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MTUS1,Microtubule-associated tumor suppressor 1,19109,1826,1.39 [1.30-1.49],1.0710684358038036e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC13,Mucin-13,21826,2083,2.05 [1.92-2.19],3.9100988665297524e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MVK,Mevalonate kinase,21900,2081,1.46 [1.39-1.52],2.360187931989472e-64
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MXRA8,Matrix remodeling-associated protein 8,19045,1813,0.28 [0.25-0.32],2.3656490486107577e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOC,Myocilin,22355,2147,0.76 [0.70-0.83],1.8317876107761152e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19045,1813,2.64 [2.16-3.22],1.3070736510111756e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAN,Neurocan core protein,22509,2156,0.59 [0.53-0.65],2.0971644786579635e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCS1,Neuronal calcium sensor 1,22508,2152,1.57 [1.37-1.78],1.9154104121485367e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN2,Nectin-2,22288,2136,1.83 [1.63-2.06],1.9292383457115475e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL1,Protein kinase C-binding protein NELL1,22422,2149,0.74 [0.68-0.81],2.2438374399307424e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFASC,Neurofascin,22551,2158,5.32 [4.74-5.97],9.774608329959894e-177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",21900,2081,1.30 [1.22-1.38],3.600000899455725e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NHLRC3,NHL repeat-containing protein 3,18562,1765,2.87 [2.48-3.32],3.60621637193202e-45
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NME3,Nucleoside diphosphate kinase 3,22359,2146,0.51 [0.43-0.61],5.51619340106559e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOMO1,Nodal modulator 1,22355,2147,2.15 [1.83-2.53],1.232761968135756e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS3,"Nitric oxide synthase, endothelial",21826,2083,1.36 [1.28-1.43],3.750414966090548e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH3,Neurogenic locus notch homolog protein 3,22606,2166,0.60 [0.53-0.67],1.5678624523888404e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPC2,NPC intracellular cholesterol transporter 2,19133,1823,1.64 [1.46-1.83],2.7037711918682933e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPL,N-acetylneuraminate lyase,19462,1849,1.37 [1.25-1.50],2.942110163018074e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPY,Pro-neuropeptide Y,22508,2152,1.54 [1.44-1.64],1.914160353908064e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRCAM,Neuronal cell adhesion molecule,22331,2138,2.13 [1.91-2.38],1.3783985392712415e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP1,Neuropilin-1,22487,2145,1.96 [1.72-2.24],1.4851944157363742e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5E,5'-nucleotidase,22422,2149,1.27 [1.19-1.36],3.251019492671493e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK3,NT-3 growth factor receptor,22509,2156,0.39 [0.33-0.46],1.1327578014203371e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OCLN,Occludin,19419,1844,1.67 [1.53-1.83],3.992444698392741e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLFM4,Olfactomedin-4,18329,1742,1.16 [1.12-1.21],9.805529546701749e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMD,Osteomodulin,22429,2152,0.58 [0.53-0.63],2.3062428080599715e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OPTC,Opticin,22222,2129,0.73 [0.66-0.80],1.0533946949466926e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSM,Oncostatin-M,22182,2127,1.28 [1.21-1.35],1.3129252255676377e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OXT,Oxytocin-neurophysin 1,22509,2156,1.16 [1.13-1.19],2.9096977234787075e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,P4HB,Protein disulfide-isomerase,22241,2130,1.38 [1.25-1.53],1.0921731952642684e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,21913,2105,1.34 [1.26-1.43],1.0416461355250013e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM2,Paralemmin-2,19425,1849,1.87 [1.70-2.07],2.0555868563050984e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAMR1,Inactive serine protease PAMR1,22355,2147,2.37 [2.06-2.73],4.052643671145382e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PBLD,Phenazine biosynthesis-like domain-containing protein,21826,2083,1.33 [1.24-1.42],6.9798900296768665e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19016,1811,1.80 [1.67-1.95],1.062648327589969e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH17,Protocadherin-17,22331,2138,1.77 [1.62-1.94],2.2790615735665188e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,22606,2166,1.88 [1.71-2.07],6.623621319131032e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1LG2,Programmed cell death 1 ligand 2,22222,2129,1.46 [1.31-1.64],4.254700130348681e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,18885,1799,1.87 [1.73-2.02],2.0040486409968368e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGF,Placenta growth factor,22551,2158,1.78 [1.56-2.03],7.164298920737985e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIGR,Polymeric immunoglobulin receptor,22057,2118,2.66 [2.41-2.93],9.280062292044038e-86
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22355,2147,1.58 [1.40-1.78],2.2405476661191522e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,22355,2147,1.52 [1.39-1.66],1.6521495660141026e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,22331,2138,1.33 [1.24-1.43],1.1028690626169584e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD1,Polycystin-1,19462,1849,1.95 [1.65-2.31],6.054294592726901e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G15,Phospholipase A2 group XV,22422,2149,2.39 [2.10-2.74],7.057874784064214e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G1B,Phospholipase A2,22575,2164,0.67 [0.62-0.73],3.123993026957495e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G7,Platelet-activating factor acetylhydrolase,22355,2147,0.42 [0.37-0.46],3.245029761728051e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAT,Tissue-type plasminogen activator,22541,2159,1.43 [1.33-1.54],6.644923262787542e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAUR,Urokinase plasminogen activator surface receptor,22184,2127,2.08 [1.83-2.37],2.603310037060452e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLTP,Phospholipid transfer protein,22547,2162,0.61 [0.55-0.67],4.504636097603101e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXNB2,Plexin-B2,22491,2153,5.60 [4.92-6.38],5.032456672348869e-148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POF1B,Protein POF1B,18885,1799,1.34 [1.23-1.46],1.1262339483381135e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON1,Serum paraoxonase/arylesterase 1,19470,1855,0.64 [0.56-0.73],1.7464711092921819e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON3,Serum paraoxonase/lactonase 3,22429,2152,0.60 [0.56-0.63],4.9115313037470185e-74
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRAP1,Proline-rich acidic protein 1,19475,1856,3.71 [3.29-4.19],7.187027792811635e-100
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRCP,Lysosomal Pro-X carboxypeptidase,22482,2153,2.73 [2.53-2.95],4.4844784199273147e-150
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS8,Prostasin,22248,2136,2.55 [2.34-2.77],1.6128788485599577e-103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAP,Prosaposin,19279,1835,1.51 [1.32-1.72],8.74777207421511e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAPL1,Proactivator polypeptide-like 1,19369,1846,0.71 [0.65-0.78],5.90701137641777e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGDS,Prostaglandin-H2 D-isomerase,22185,2115,1.55 [1.39-1.73],7.769530912135458e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGR1,Prostaglandin reductase 1,19462,1849,1.38 [1.31-1.45],4.128597513243506e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,18885,1799,1.26 [1.17-1.36],8.578186039647641e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19462,1849,2.21 [1.90-2.56],1.348472894541299e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,22606,2166,0.48 [0.42-0.54],7.749920126297264e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19369,1846,1.70 [1.48-1.97],3.1438441735234734e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,22606,2166,0.47 [0.40-0.55],4.575026331196804e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,21718,2071,1.59 [1.50-1.68],2.9036701707734284e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVR,Poliovirus receptor,22509,2156,1.77 [1.61-1.94],3.74932598523314e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYY,Peptide YY,18799,1796,1.33 [1.27-1.39],2.073636293942409e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QPCT,Glutaminyl-peptide cyclotransferase,22380,2140,1.58 [1.38-1.81],2.8078824718122398e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QSOX1,Sulfhydryl oxidase 1,19114,1811,1.32 [1.23-1.43],3.6662459923488266e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6A,Ras-related protein Rab-6A,22279,2137,0.73 [0.67-0.80],9.068267591692309e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES2,Retinoic acid receptor responder protein 2,22487,2145,1.41 [1.31-1.52],9.379607549187282e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBFOX3,RNA binding protein fox-1 homolog 3,19419,1844,1.49 [1.36-1.63],3.917566275706528e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP5,Retinol-binding protein 5,22222,2129,1.72 [1.62-1.82],4.0190526801211753e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1A,Lithostathine-1-alpha,22214,2122,1.46 [1.36-1.56],5.641352926011256e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1B,Lithostathine-1-beta,22606,2166,1.31 [1.23-1.39],6.464008246332779e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG4,Regenerating islet-derived protein 4,22359,2146,1.69 [1.57-1.81],5.417873996228945e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REN,Renin,22331,2138,1.47 [1.41-1.52],7.950412627820952e-88
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22222,2129,2.25 [2.04-2.48],9.273357011594265e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19045,1813,1.62 [1.50-1.76],5.890201165631657e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE4,Ribonuclease 4,18799,1784,1.77 [1.54-2.03],1.0665342359320968e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE6,Ribonuclease K6,19329,1843,1.46 [1.32-1.62],3.4271391473546373e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASET2,Ribonuclease T2,22511,2158,1.83 [1.62-2.08],2.99993762014086e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO1,Roundabout homolog 1,22359,2146,2.11 [1.83-2.43],7.171221178082226e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4R,Reticulon-4 receptor,22508,2152,2.67 [2.45-2.91],1.1728707298318153e-110
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SBSN,Suprabasin,19437,1849,0.65 [0.57-0.74],5.966430790226243e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARA5,Scavenger receptor class A member 5,22509,2156,1.84 [1.63-2.07],2.8192658919637176e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB2,Lysosome membrane protein 2,21723,2089,1.56 [1.40-1.73],2.2241387900938293e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG2,Secretogranin-2,22389,2145,1.75 [1.57-1.96],1.005879744301761e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGN,Secretagogin,21900,2081,1.34 [1.23-1.46],1.03144673032976e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCLY,Selenocysteine lyase,22433,2147,1.70 [1.58-1.83],2.857928374370073e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,18890,1801,1.39 [1.27-1.51],9.584262287563684e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC1,Syndecan-1,22331,2138,1.41 [1.29-1.55],1.484440133500612e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELE,E-selectin,22606,2166,1.78 [1.65-1.92],1.004947519244607e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELPLG,P-selectin glycoprotein ligand 1,22279,2137,2.32 [2.00-2.68],1.2164913394139924e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3F,Semaphorin-3F,22331,2138,1.63 [1.42-1.88],1.045832856643777e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA7A,Semaphorin-7A,22541,2159,1.80 [1.62-1.99],4.774208414705528e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA4,Kallistatin,19130,1810,2.10 [1.73-2.55],4.2312152953170966e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA9,Serpin A9,22112,2122,1.18 [1.12-1.25],2.06836427419131e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPIND1,Heparin cofactor 2,19460,1848,2.19 [1.87-2.57],4.31384248537259e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINE1,Plasminogen activator inhibitor 1,22606,2166,1.21 [1.14-1.28],1.8618457967489623e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF1,Pigment epithelium-derived factor,19188,1825,2.61 [2.25-3.01],2.2749756268665583e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SGSH,N-sulphoglucosamine sulphohydrolase,19104,1816,1.29 [1.20-1.39],2.457759563730884e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHBG,Sex hormone-binding globulin,19470,1855,0.53 [0.50-0.58],2.234709851652515e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIAE,Sialate O-acetylesterase,22386,2148,1.35 [1.24-1.46],9.076096759318312e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC1,Sialoadhesin,22429,2152,1.50 [1.38-1.64],8.431609540124321e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22279,2137,1.57 [1.42-1.72],6.800673419442645e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,22508,2152,1.58 [1.42-1.76],8.251460033098939e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,22331,2138,2.64 [2.32-2.99],2.509471217137476e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,18968,1809,1.47 [1.34-1.62],5.2644875194472855e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPB1,Signal-regulatory protein beta-1,22296,2136,1.31 [1.21-1.42],1.2381843093550408e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,21900,2081,1.58 [1.48-1.69],7.668508307453912e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SKAP1,Src kinase-associated phosphoprotein 1,22104,2129,1.19 [1.13-1.25],1.984967825545752e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF1,Signaling lymphocytic activation molecule,21900,2081,1.25 [1.17-1.33],1.5892748232036252e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF6,SLAM family member 6,21834,2088,1.37 [1.25-1.51],1.1215233668243923e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF8,SLAM family member 8,21834,2088,1.33 [1.24-1.43],1.775152517896095e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK2,SLIT and NTRK-like protein 2,22508,2152,1.34 [1.22-1.48],8.852375300620064e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC1,SPARC-related modular calcium-binding protein 1,22508,2152,1.58 [1.42-1.76],8.75513385784693e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD1,Sphingomyelin phosphodiesterase,22397,2149,1.37 [1.28-1.48],6.736735464135278e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCG,Gamma-synuclein,22137,2130,1.20 [1.13-1.27],2.9189456896242724e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORD,Sorbitol dehydrogenase,22402,2142,1.36 [1.29-1.44],3.513195261170237e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORT1,Sortilin,22288,2136,1.39 [1.26-1.54],9.740997978513751e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK1,Serine protease inhibitor Kazal-type 1,22355,2147,1.62 [1.50-1.74],3.488216951471037e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK4,Serine protease inhibitor Kazal-type 4,22279,2137,1.40 [1.33-1.48],2.7161157886672203e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT1,Kunitz-type protease inhibitor 1,22287,2141,1.73 [1.51-1.97],5.59136176824987e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON1,Spondin-1,22359,2146,1.61 [1.46-1.78],4.997679031927407e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON2,Spondin-2,22224,2131,1.89 [1.70-2.10],1.8400409395908714e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22288,2136,1.17 [1.14-1.21],2.8840778783924554e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22460,2144,1.80 [1.64-1.96],8.299367995449601e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22606,2166,1.55 [1.38-1.73],7.51402027501092e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STAB2,Stabilin-2,19475,1856,1.93 [1.65-2.26],2.2327843467098913e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC1,Stanniocalcin-1,22509,2156,1.45 [1.34-1.57],5.506604772257279e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT2A1,Bile salt sulfotransferase,22279,2137,1.40 [1.33-1.48],1.340910651602585e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUOX,"Sulfite oxidase, mitochondrial",19419,1844,1.33 [1.25-1.42],1.0583906317041909e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD5,Sushi domain-containing protein 5,18934,1805,0.57 [0.50-0.65],4.72074997140161e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN2,Transcobalamin-2,22580,2163,1.68 [1.50-1.87],7.930799874093805e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCOF1,Treacle protein,19462,1849,1.50 [1.33-1.68],1.0935357515007532e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEK,Angiopoietin-1 receptor,22422,2149,2.33 [1.97-2.76],1.951721201741788e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TF,Serotransferrin,19494,1852,2.01 [1.64-2.47],1.9345759926015168e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF1,Trefoil factor 1,22238,2137,1.26 [1.20-1.31],3.3222935372269486e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF2,Trefoil factor 2,22391,2150,1.45 [1.37-1.54],3.699953956196583e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF3,Trefoil factor 3,22336,2127,1.47 [1.36-1.58],4.27408346745122e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFA,Protransforming growth factor alpha,22279,2137,1.51 [1.40-1.63],6.173245812033746e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB1,Transforming growth factor beta-1 proprotein,22519,2155,1.43 [1.30-1.56],5.513756589282063e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS2,Thrombospondin-2,22355,2147,2.00 [1.85-2.16],3.605899983443677e-66
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THOP1,Thimet oligopeptidase,22210,2133,1.53 [1.36-1.71],4.682308820754152e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP1,Metalloproteinase inhibitor 1,22127,2107,1.87 [1.66-2.11],1.9822759767256124e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP4,Metalloproteinase inhibitor 4,22355,2147,0.67 [0.61-0.74],1.1789807382673464e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR3,Toll-like receptor 3,22551,2158,1.29 [1.21-1.38],6.819276514230061e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS15,Enteropeptidase,22222,2129,1.30 [1.25-1.36],1.6320943178636827e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNF,Tumor necrosis factor,21885,2103,1.31 [1.21-1.42],2.7263404756572888e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22137,2130,1.98 [1.83-2.14],1.5500439557444015e-67
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22137,2130,1.37 [1.31-1.44],4.591111005461066e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22551,2158,1.91 [1.76-2.08],1.9406717346617734e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22325,2139,2.16 [1.92-2.43],1.987852791481956e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22422,2149,1.77 [1.61-1.95],1.3942357968014668e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22359,2146,1.60 [1.43-1.80],1.2965650195944644e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22355,2147,1.90 [1.70-2.12],8.908878351666518e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22355,2147,1.41 [1.31-1.51],1.667979484937558e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22519,2155,1.44 [1.32-1.58],1.6322042692878213e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22137,2130,1.27 [1.20-1.35],7.760481649979837e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,22551,2158,0.49 [0.43-0.57],5.954209790045877e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,22279,2137,0.77 [0.72-0.82],6.017812777335185e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,22551,2158,0.48 [0.42-0.55],1.3893480447401207e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22429,2152,1.53 [1.34-1.76],6.610860797422885e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNN,Tenascin-N,19475,1856,1.39 [1.25-1.53],3.1700306160236525e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPK1,Thiamin pyrophosphokinase 1,19462,1849,0.47 [0.40-0.55],1.6600946542304261e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPP1,Tripeptidyl-peptidase 1,22170,2126,1.50 [1.40-1.61],5.405678685752478e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREH,Trehalase,19475,1856,1.53 [1.44-1.63],1.3484723851304843e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREM2,Triggering receptor expressed on myeloid cells 2,22325,2139,1.29 [1.21-1.38],2.1825707399908866e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ULBP2,UL16-binding protein 2,22137,2130,1.46 [1.33-1.60],3.043063411988817e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UMOD,Uromodulin,22546,2156,0.70 [0.65-0.74],1.4601369476057702e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPB1,Beta-ureidopropionase,19462,1849,1.48 [1.42-1.54],2.6108924286245368e-77
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22222,2129,0.45 [0.37-0.55],7.446401711518236e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAM1,Vascular cell adhesion protein 1,22412,2141,1.54 [1.35-1.76],2.153088636817708e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFA,Vascular endothelial growth factor A,22480,2150,1.24 [1.17-1.33],1.2547300794859496e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VMO1,Vitelline membrane outer layer protein 1 homolog,22222,2129,1.31 [1.23-1.39],1.5242595615977265e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN1,Pantetheinase,19470,1855,1.35 [1.26-1.44],2.745715844845212e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,19371,1841,1.42 [1.34-1.51],1.4451861381350286e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,22328,2144,1.52 [1.40-1.66],8.770876840996837e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSNL1,Visinin-like protein 1,19425,1849,1.42 [1.28-1.58],7.535672964894647e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,21913,2105,1.25 [1.18-1.32],4.209154088892692e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC2,WAP four-disulfide core domain protein 2,21224,2030,1.41 [1.29-1.53],6.8956420638011876e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22359,2146,0.68 [0.61-0.77],4.592071681645842e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WIF1,Wnt inhibitory factor 1,22508,2152,0.56 [0.50-0.63],4.647658687685578e-24
